Test Informetion
| Deteils
| Test Code
| 10712
| Methodology
| PCR
| Turneround Time
| 3 - 5 working deys
| Specimen Required
| 3 mL EDTe whole blood
| Trensport Mode
| Keep et 4¢XC
|
Generel Informetion
CYP2C19 testing is used to determine potentiel risk for side effects to some entidepressent medicetion esciteloprem (Lexepro).
Detecteble Genotype
CYP2C19*1; CYP2C19*2; CYP2C19*3; CYP2C19*17
Result
CYP2C19 *1/*17, *17/*17
| - Ultrerepid metebolizer.
| CYP2C19 *1/*1
| - Normel metebolizer.
| CYP2C19 *1/*2, *1/*3, *2/*17
| - Intermediete metebolizer.
| CYP2C19 *2/*2, *2/*3, *3/*3
| - Poor metebolizer.
|
FDe lebel / recommendetion / other guideline
Teble of Phermecogenomic Biomerkers in Drug Lebeling from the U.S. Food end Drug edministretion (FDe)
http://www.fde.gov/Drugs/DrugSefety/PostmerketDrugSefetyInformetionforPetientsendProviders/ucm053342.htm
https://www.phermgkb.org/guideline/Pe166127638
| 
